110 related articles for article (PubMed ID: 11002624)
1. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders.
Patel BR
J Indian Med Assoc; 2000 May; 98(5):250-2. PubMed ID: 11002624
[TBL] [Abstract][Full Text] [Related]
2. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
Dreiser RL; Le Parc JM; Vélicitat P; Lleu PL
Inflamm Res; 2001 Mar; 50 Suppl 1():S17-23. PubMed ID: 11339516
[TBL] [Abstract][Full Text] [Related]
3. [Meloxicam: intramuscular administration in rheumatology].
Tsvetkova ES
Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
Degner F; Sigmund R; Zeidler H
Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
[TBL] [Abstract][Full Text] [Related]
5. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
Cheng TT; Lai HM; Chiu CK; Chem YC
Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and intolerance of meloxicam in injection and tablet form].
Tiurin VP; Rakov AL
Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
[No Abstract] [Full Text] [Related]
7. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group.
Colberg K; Hettich M; Sigmund R; Degner FL
Curr Med Res Opin; 1996; 13(7):363-77. PubMed ID: 8862936
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine.
Valat JP; Accardo S; Reginster JY; Wouters M; Hettich M; Lieu PL;
Inflamm Res; 2001 Mar; 50 Suppl 1():S30-4. PubMed ID: 11339519
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
Baiza-Duran LM; Quintana-Hau J; Tornero-Montaño R; Ortiz MI; Castañeda-Hernández G; Alanis-Villarreal L; Avalos-Urzua G; Bustos-Zermeño R; Domene-Hinojosa JL; Gómez-Bastar P; Ibañez-Hernandez MA; Morales-Gómez ME; Velasco-Gallegos G; Villar-Kuri J
Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
Goei Thè HS; Lund B; Distel MR; Bluhmki E
Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
[TBL] [Abstract][Full Text] [Related]
11. [Meloxicam--the balance of efficacy and safety].
Morović-Vergles J
Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
[TBL] [Abstract][Full Text] [Related]
12. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
Hosie J; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():39-43. PubMed ID: 8630635
[TBL] [Abstract][Full Text] [Related]
13. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
Tavakoli M
Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
[TBL] [Abstract][Full Text] [Related]
14. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77].
Fenn GC; Morant SV
Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122
[No Abstract] [Full Text] [Related]
15. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
[TBL] [Abstract][Full Text] [Related]
16. Low-dose meloxicam (Vivlodex) for osteoarthritis pain.
Med Lett Drugs Ther; 2016 Mar; 58(1490):35-6. PubMed ID: 26963155
[No Abstract] [Full Text] [Related]
17. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Singh G; Lanes S; Triadafilopoulos G
Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
[TBL] [Abstract][Full Text] [Related]
18. [The selective cox-2 inhibitor meloxicam and salicylate therapy].
Tóth K
Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964
[TBL] [Abstract][Full Text] [Related]
19. [Meloxicam].
Sternon J; Appelboom T
Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
[TBL] [Abstract][Full Text] [Related]
20. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
